written on 20.05.2014

Pyott's 'conflict of interest' thwarting Valeant's buyout efforts, Ackman says


Is a position as one of the industry&#39;s top-paid CEOs enough to prompt Allergan&#39;s chief to dis Valeant&#39;s buyout efforts? Investor and takeover partner Bill Ackman thinks so, and he made that argument in a public letter Monday.